| Literature DB >> 31375179 |
Abstract
The progressive natural history underlying type 2 diabetes often necessitates the use of multiple anti-hyperglycemic medications to achieve therapeutic goals and targets. The associated complexity of these regimens presents significant challenges to both physicians and patients. Fixed-dose oral and fixed-ratio injectable combination agents offer significant potential to simplify and consolidate therapy and lessen barriers to adherence.Entities:
Keywords: adherence; diabéte de type 2; fixed dose combination; fixed ratio combination; observance; traitement combiné en proportion fixe; traitement combiné à dose fixe; type 2 diabetes
Year: 2019 PMID： 31375179 DOI： 10.1016/j.jcjd.2019.05.005
Source DB: PubMed Journal: Can J Diabetes ISSN： 1499-2671 Impact factor: 4.190